GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Cyclically Adjusted Revenue per Share

Caplin Point Laboratories (BOM:524742) Cyclically Adjusted Revenue per Share : ₹131.42 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Caplin Point Laboratories's adjusted revenue per share for the three months ended in Mar. 2024 was ₹59.680. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹131.42 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Caplin Point Laboratories's average Cyclically Adjusted Revenue Growth Rate was 21.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Caplin Point Laboratories was 23.60% per year. The lowest was 23.60% per year. And the median was 23.60% per year.

As of today (2024-06-23), Caplin Point Laboratories's current stock price is ₹1420.80. Caplin Point Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹131.42. Caplin Point Laboratories's Cyclically Adjusted PS Ratio of today is 10.81.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Caplin Point Laboratories was 12.80. The lowest was 5.51. And the median was 8.57.


Caplin Point Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Caplin Point Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Cyclically Adjusted Revenue per Share Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 69.56 86.51 108.22 131.42

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.22 114.95 120.35 126.28 131.42

Competitive Comparison of Caplin Point Laboratories's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Cyclically Adjusted PS Ratio falls into.



Caplin Point Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Caplin Point Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=59.68/153.0345*153.0345
=59.680

Current CPI (Mar. 2024) = 153.0345.

Caplin Point Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 6.342 94.103 10.314
201409 7.570 96.780 11.970
201412 8.064 96.780 12.751
201503 8.421 97.163 13.263
201506 9.278 99.841 14.221
201509 10.264 101.753 15.437
201512 10.486 102.901 15.595
201603 10.840 102.518 16.181
201606 11.261 105.961 16.264
201609 12.670 105.961 18.299
201612 13.626 105.196 19.823
201703 15.586 105.196 22.674
201706 16.283 107.109 23.265
201709 17.313 109.021 24.302
201712 18.642 109.404 26.076
201803 19.225 109.786 26.798
201806 19.252 111.317 26.467
201809 22.140 115.142 29.426
201812 20.926 115.142 27.813
201903 24.655 118.202 31.920
201906 24.764 120.880 31.351
201909 29.773 123.175 36.990
201912 29.929 126.235 36.283
202003 25.780 124.705 31.636
202006 31.479 127.000 37.932
202009 35.159 130.118 41.351
202012 36.012 130.889 42.105
202103 34.703 131.771 40.303
202106 39.224 134.084 44.768
202109 39.915 135.847 44.965
202112 42.695 138.161 47.291
202203 44.364 138.822 48.906
202206 45.313 142.347 48.715
202209 46.962 144.661 49.680
202212 49.026 145.763 51.472
202303 51.287 146.865 53.442
202306 51.790 150.280 52.739
202309 53.761 151.492 54.308
202312 57.346 152.924 57.387
202403 59.680 153.035 59.680

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Caplin Point Laboratories  (BOM:524742) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Caplin Point Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1420.80/131.42
=10.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Caplin Point Laboratories was 12.80. The lowest was 5.51. And the median was 8.57.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Caplin Point Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines